☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Envision
Alnylam Reports Results of Givosiran in P-III ENVISION Study to Treat Acute Hepatic Porphyria
April 15, 2019
Alnylam Reports Positive Result of Givosiran in P-III ENVISION Study for Acute Hepatic Porphyria (AHP)
March 7, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.